These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24522993)

  • 1. Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma.
    Nathan H; Herlong HF; Gurakar A; Li Z; Koteish AA; Bridges JF; Pawlik TM
    Ann Surg Oncol; 2014 Jun; 21(6):1844-51. PubMed ID: 24522993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma.
    Nathan H; Segev DL; Bridges JF; Massie AB; Cameron AM; Hirose K; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2013 Feb; 20(2):448-56. PubMed ID: 22941170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding surgical decision making in early hepatocellular carcinoma.
    Nathan H; Bridges JF; Schulick RD; Cameron AM; Hirose K; Edil BH; Wolfgang CL; Segev DL; Choti MA; Pawlik TM
    J Clin Oncol; 2011 Feb; 29(6):619-25. PubMed ID: 21205759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Serra C; Colecchia A; Maroni L; Venerandi L; Ercolani G; Pinna AD
    Dig Liver Dis; 2014 Mar; 46(3):257-63. PubMed ID: 24284006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
    Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
    Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment before liver transplantation for HCC.
    Belghiti J; Carr BI; Greig PD; Lencioni R; Poon RT
    Ann Surg Oncol; 2008 Apr; 15(4):993-1000. PubMed ID: 18236111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatocellular carcinoma.
    Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
    J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Peng ZW; Chen MS
    Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation.
    Perry JF; Charlton B; Koorey DJ; Waugh RC; Gallagher PJ; Crawford MD; Verran DJ; McCaughan GW; Strasser SI
    Liver Int; 2007 Nov; 27(9):1240-8. PubMed ID: 17919236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.